Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 7:54 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 673–696 of 995 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Comparison control condition Clear all

Conditions: Bipolar Disorder
Interventions: Olanzapine, Paliperidone ER, Placebo; Drug
Lead sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 768 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 16
States / cities: Scottsdale, Arizona • Riverside, California • San Diego, California + 13 more

Conditions: Alzheimer Disease
Interventions: florbetapir F 18; Drug
Lead sponsor: Avid Radiopharmaceuticals; Industry
Eligibility: 35 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 3
States / cities: West Palm Beach, Florida • North East, Maryland • Clementon, New Jersey

Conditions: Bipolar Disorder, Depression
Interventions: Cariprazine, Placebo; Drug
Lead sponsor: Forest Laboratories; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 493 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 42
States / cities: Birmingham, Alabama • Dothan, Alabama • Phoenix, Arizona + 37 more

Conditions: CBD, Hand Osteoarthritis
Interventions: CBD, Shea Butter; Drug
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Frail Elderly, Cognitive Impairment, Mobility Limitation, Depressive Symptoms
Interventions: Tai Ji Quan: Moving for Better Balance, Behavioral Activation, Resource Navigation, Enhanced Usual Care; Behavioral · Other
Lead sponsor: University of Vermont; Other
Eligibility: 65 Years and older
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 3
States / cities: Augusta, Maine • Lyme, New Hampshire • Montpelier, Vermont

Conditions: Lymphocyte Depletion
Interventions: SBRT with additional treatment planning dose optimization, SBRT with standard of care planning only, Blood Draws; Radiation · Diagnostic Test
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Gastrointestinal Disease, Gastrointestinal Dysfunction
Interventions: Biopsy imaged by Optical imaging device.; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Dry Eye
Interventions: Reproxalap Ophthalmic Solution (0.25%) QID, Vehicle Ophthalmic Solution QID, Reproxalap Ophthalmic Solution (0.25%) QID to BID, Vehicle Ophthalmic Solution QID to BID; Drug
Lead sponsor: Aldeyra Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 422 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Newport Beach, California

Conditions: Eating Disorders in Adolescence
Interventions: The Body Project; Behavioral
Lead sponsor: University of Colorado, Boulder; Other
Eligibility: Female only
Enrollment: 74 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Boulder, Colorado

Conditions: Alzheimer's Disease
Interventions: T3D-959, Placebo Comparator; Drug · Other
Lead sponsor: T3D Therapeutics, Inc.; Industry
Eligibility: 50 Years to 90 Years
Enrollment: 376 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Episodic Memory
Interventions: Visual Memory Encoding and Retrieval Task During fMRI; Behavioral
Lead sponsor: Brown University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Orthopedic Trauma Surgery Patients, Postoperative Pain, Opioid Use, Depression, Post-traumatic Stress Disorder (PTSD)
Interventions: Ketamine, standard general anesthesia; Drug
Lead sponsor: Texas Tech University Health Sciences Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: Lubbock, Texas

Conditions: Cardiovascular Disease
Interventions: Healthy American Control Diet, Dark Chocolate/Cocoa Diet, Almond Diet, Dark Chocolate/Cocoa + Almond Diet; Other
Lead sponsor: Penn State University; Other
Eligibility: 30 Years to 70 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Anxiety Disorders
Interventions: Cognitive-behavioral group therapy; Behavioral
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 8 Years to 12 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2011
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Autoimmune
Interventions: Sample Collection; Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2023
U.S. locations: 2
States / cities: New Haven, Connecticut • New York, New York

Conditions: Menopause, Hot Flashes
Interventions: Shatavari (Asparagus racemosus) Extract, Placebo; Dietary Supplement · Other
Lead sponsor: India Glycols Ltd; Industry
Eligibility: 45 Years to 60 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New Port Richey, Florida

Conditions: Chronic Pain
Interventions: Intraoperative Parameter Testing, Proprioception Testing During Stimulation, Gait Analysis During Stimulation; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 80 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Parkinson Disease
Interventions: Personal KinetiGraph® (PKG®) Watch, Personal KinetiGraph® (PKG®) Report; Device
Lead sponsor: Global Kinetics Corporation; Industry
Eligibility: 46 Years to 83 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 17
States / cities: Fayetteville, Arkansas • Little Rock, Arkansas • Menlo Park, California + 14 more

Conditions: Heart Disease, Mitral Regurgitation, Heart Valve Disease, Mitral Valve Insufficiency
Interventions: Beta-blocker therapy (TOPROL-XL® ); Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Heart Failure With Preserved Ejection Fraction
Interventions: sacubitril/valsartan, Enalapril, Valsartan, Placebo to match sacubitril/valsartan, Placebo to match enalapril, Placebo to match valsartan; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 45 Years and older
Enrollment: 2,572 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 32
States / cities: Andalusia, Alabama • Mobile, Alabama • Beverly Hills, California + 29 more

Conditions: Dry Eye, Dry Eye Syndromes
Interventions: Reproxalap Ophthalmic Solution (0.25%), Vehicle Opthalmic Solution; Drug
Lead sponsor: Aldeyra Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 329 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Angiography
Interventions: Endovascular Diagnostic Procedures; Device
Lead sponsor: Cardiovascular Associates of the Delaware Valley; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Camden, New Jersey

Conditions: Opioid Use Disorder, Opioid Withdrawal, Substance Use Disorders
Interventions: Ibogaine Hydrochloride, Extended-release naltrexone injection, 380 mg, Matching Oral Placebo, Matching Intramuscular Placebo, My-E-Health SENTINEL Digital Monitoring and Human-Gated Escalation Platform, Standardized Psychological Preparation, Integration and Recovery Support, Garmin-Enabled Longitudinal Wellness Monitoring; Drug · Device · Behavioral + 1 more
Lead sponsor: Clive Michelsen; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Basalt, Colorado

Conditions: Xerostomia, Hyperthyroidism, Thyroid Cancer
Interventions: Radioiodine; Other
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 3 Years to 55 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

A Study to Evaluate the Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Delaying the Recurrence of Symptoms in Bipolar I Disorder

A Study of Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers

Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder

Is Topical CBD Effective in Treating Thumb Joint Arthritis

A Community Health Worker Program to Support Rural Older Adults

Lymphocyte Depletion and Change in Lymphocyte Functionality

Optical Imaging of Gastrointestinal Biopsy Samples and Their Correlation With Histology

The RENEW Trial: A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Adaptive Phase 3 Clinical Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease

The Peer-Delivered Body Project for Young Women in High School

A Phase 2b/3 Clinical Study Evaluating T3D-959 in Mild-to-Moderate Alzheimer's Disease Subjects

The Dynamics of Representational Change Underlying Recall

Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients

Effects of Polyphenolic-rich Dark Chocolate/Cocoa and Almonds on Cardiovascular Disease Risk Factors

Preventing Anxiety Disorders in Urban Youth

The Human Microbiome in Immune-Mediated Diseases

Randomized Evaluation of Natural Extract for Menopausal Wellness (RENEW)

Effect of Epidural Stimulation on Muscle Activation and Sensory Perception

Utilization of Target Ranges to Treat Parkinson's Disease With the PKG

Using Beta Blockers to Treat Mitral Regurgitation

A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients

The TRANQUILITY Trial: Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye Disease

Mynx M5 One Hour Ambulation Study

Medically Supervised Ibogaine With 12-Month Digital Recovery Support for Opioid Use Disorder

Effect of Childhood Radioiodine Therapy on Salivary Function